Work

Pharmacokinetic and Pharmacodynamic Profile of New Biosimilar Filgrastim XM02 Equivalent to Marketed Filgrastim Neupogen®

Year: 2009

Type: article

Study design: Clinical Trial

Source: BioDrugs

DOI: 10.2165/00063030-200923010-00005

Authors: Heinz Lubenau, Peter Bias, Anne-Katrin Maly, Karl Ernst Siegler, Kai Mehltretter

Institution: Clinical Research Services

Language: English

Topic: Biosimilars and Bioanalytical Methods

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W47829030

FWCI: 2.156

Cites: 17

Cited by: 60

Related to: 10